Skip to content
Open access

Amlodipine besylate and valsartan combined mucoadhesive buccal patch formulations: In-vitro release and ex-vivo permeation studies.

Sep 2026 · Pakistan Journal of Pharmaceutical Sciences · Vol 40 1, pp. 40-54 · 0 citations · 17 references
Medicine

Abstract

Background

Oral fixed-dose combinations of Amlodipine Besylate and Valsartan are widely prescribed for hypertension but are associated with first-pass metabolism and variable bioavailability. Buccal drug delivery provides a favorable substitute to improve systemic availability and provide sustained release.

Objectives

This study aimed to develop and assess mucoadhesive buccal patches containing Amlodipine Besylate and Valsartan to enhance bioavailability and achieve controlled drug release over 24 hours.

Methods

Buccal patches were developed via the solvent-casting method using Hydroxypropyl Methylcellulose, Polyvinylpyrrolidone, Methylcellulose, Sodium Alginate and Metolose as backing membrane polymers. All the prepared films were evaluated for physicochemical parameters by means of X-ray Diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), Scanning electron microscopy (SEM) and in vitro and ex vivo drug release. In-vitro drug release was studied with USP Apparatus II (paddle method) in 500 ml 6.8 pH phosphate buffer at 37 ± 0.5°C and 50 rpm for 24 hours. Ex vivo permeation studies were performed using a Franz diffusion cell fitted with rabbit buccal mucosa under similar conditions.

Results

The formulations generally exhibited acceptable physicochemical characteristics within the evaluated parameters. The developed films appeared transparent with a uniform distribution of components. FTIR analysis did not indicate any detectable incompatibility or significant interaction between the drugs and excipients under the study conditions. Among all formulations, F1 contained the highest drug release and permeation. After 24 hours, cumulative release reached 84.45% for amlodipine and 88.03% for valsartan. Ex-vivo permeation was 76.31% and 78.42% for amlodipine and valsartan, respectively. Furthermore, buccal films' histopathological and stability studies were found to be harmless and functioned as an efficient dosage system.

Conclusion

The developed mucoadhesive buccal patches successfully delivered both drugs in a sustained manner. Formulation F1 showed superior release and permeation profiles, suggesting its potential as substitute to conventional oral dosage forms for improved hypertension management.

Read PDF

Similar papers

Open access Oct 2026

Formulation and Evaluation of Mucoadhesive Buccal Patch of Clomipramine Hydrochloride for Enhanced Buccal Drug Delivery

Background: Mucoadhesive buccal patches are being investigated as alternatives to conventional oral dosage forms for drugs affected by hepatic first-pass metabolism. Objective: This study aimed to formulate and evaluate clomipramine hydrochloride buccal patches using hydroxypropyl methylcellulose (HPMC E15) and Carbopo...

B. Kousalya, A. Selvi · 0 citations
Open access Sep 2026

Formulation and In Vitro Evaluation of Meloxicam-Loaded Transdermal Patches: Effect of Polymeric Blends on Drug Release and Kinetics

Findings highlight the influence of polymeric composition on drug release behavior and support the potential of transdermal systems as an alternative to oral meloxicam therapy.

Ameen M. Alwossabi, Imad M. Taj Eldin, A. M. Al-Ghani et al. · 0 citations
Open access Oct 2026

Influence of Hydroxypropyl Methylcellulose E6–Carbopol 934P Composition on Drug Release and Buccal Mucoadhesion Time of Ondansetron Hydrochloride Tablets

Background: Ondansetron hydrochloride is a selective antagonist of serotonin receptor used to manage nausea and vomit-ing, but oral administration is limited by first-pass metabolism and may be unreliable during active vomiting. Buccal delivery may overcome these limitations. This study aimed to develop and evaluate on...

Abdullah H. al-Gamli, Abdullah H. Maad, Mohammed Alherwi et al. · 0 citations
Sep 2026

Formulation, Process Optimization, and in Vitro–in Vivo Evaluation of Buccal Effervescent Tablets of BCS Class II and Class IV Drugs: Asenapine Maleate and Telmisartan Cilexetil

Optimized formulations were evaluated for in vitro dissolution, in vitro buccal permeation through freshly excised goat mucosa using Franz diffusion cells, buccal mucosal irritation (histopathology), in vivo pharmacokinetics in New Zealand White rabbits, and 12-month ICH accelerated stability.

G. Gopi · 0 citations
Open access Sep 2026

FORMULATION AND IN VITRO, IN VIVO EVALUATION OF BUCCAL DRUG DELIVERY SYSTEM OF TIZANIDINE HCL

The buccal tablets of Tizanidine HCL showed enhanced BA a which was confirmed by in-vivo studies, and may be due to the hydrophilicity a water uptake by the tablet a were considered as optimized formulation.

Soudam Sai Sree, A. Singh, G. Rajesh · 0 citations
Open access Oct 2026

Design, Characterization and Evaluation of Transdermal Patches of Zaltoprofen

The oral route of administering drugs has several drawbacks, such as limited bioavailabilitydue to to hepatic first-pass metabolism and a tendency to generate rapid, either high or low blood level spikes. In the current study, transdermal administration of Zaltoprofen was designed to circumvent first pass metabolism an...

Neeraja Podichety, Naveen Jamjala, Anitha Bandi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.